Making biologics
- Recombinant DNA technology puts a human gene into bacteria, yeast or mammalian cells; human insulin (1982) was the first recombinant medicine.
- Monoclonal antibodies come from a single B-cell clone; the hybridoma method was developed by Köhler and Milstein in 1975.
- Polyclonal antibodies come from many clones in immunised animals or donors: antivenoms, rabies and tetanus immunoglobulins, and intravenous immunoglobulin (IVIG).
- Biologics are large, made in living cells, given by injection, and can provoke anti-drug antibodies.